According to Prelude Therapeutics Incorporated latest financial reports the company had earnings of $-121.83M in 2023-12-31, an increase of 5.54% to 2022.
Year | Earnings | Change |
---|---|---|
2023 | -$121.83M | 5.54% |
2022 | -$115.44M | 3.35% |
2021 | -$111.69M | 96.20% |
2020 | -$56.93M | - |